Log in

032300 KOREA PHARMA Co., Ltd. KRX · South Korea

KOREA PHARMA Co. (032300) news

KOREA PHARMA Co., Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 032300, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest KOREA PHARMA Co. news

We have not published a story on KOREA PHARMA Co. yet. When there is news, it will appear here.

Questions about KOREA PHARMA Co.

What is the ticker symbol of KOREA PHARMA Co.?

KOREA PHARMA Co., Ltd. trades under the ticker 032300 on KRX.

Where is KOREA PHARMA Co. listed?

KOREA PHARMA Co., Ltd. is listed on KRX.

Which country or territory is KOREA PHARMA Co. listed under?

Our directory records KOREA PHARMA Co., Ltd. under South Korea.

What does KOREA PHARMA Co. do?

Our directory classifies KOREA PHARMA Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of KOREA PHARMA Co.?

The ISIN recorded for KOREA PHARMA Co., Ltd. is KR7032300006.

Does aibio.space cover KOREA PHARMA Co.?

aibio.space lists KOREA PHARMA Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to KOREA PHARMA Co.?

Companies in our directory listed in the same country and business area as KOREA PHARMA Co.: Mezzion Pharma Co., ILSUNG IS CO., LTD., Cosmax BTI, Celltrion Pharm, Yuhan, MFC Co..

Investor discussion: KOREA PHARMA Co.

Members talk about KOREA PHARMA Co. (032300). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open KRX:032300 on TradingView.

Listing details

KOREA PHARMA Co., Ltd. is a public biotech or pharmaceutical company listed on KRX under the ticker 032300, recorded under South Korea. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
KOREA PHARMA Co., Ltd.
Ticker
032300
Listing
KRX
Country or territory
South Korea
Business scope
Pharmaceuticals: Major
ISIN
KR7032300006
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.